SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001424884-10-000040
Filing Date
2010-04-15
Accepted
2010-04-14 18:23:15
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K form10-k.htm 10-K 1694361
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECURITIES EXCHANGE ACT exhibit31-1.htm EX-31.1 16670
3 CERTIFICATION OF ACTING PRINCIPAL ACCOUNTING OFFICER PURSUANT TO SECURITIES EXCH exhibit31-2.htm EX-31.2 16719
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 exhibit32-1.htm EX-32.1 5399
5 CERTIFICATION OF ACTING PRINCIPAL ACCOUNTING OFFICER PURSUANT TO 18 U.S.C. SECTI exhibit32-2.htm EX-32.2 5638
6 DMCL GRAPHIC form10-k3.jpg GRAPHIC 55410
7 DMCL ADDRESS form10-k4.jpg GRAPHIC 24859
  Complete submission text file 0001424884-10-000040.txt   1851259
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27239 | Film No.: 10750367
SIC: 2834 Pharmaceutical Preparations